Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: A case-control study

Oral Oncology

Volumn 43, Issue 4, 2007, Pages 345-351

  Chang, Kai Ping ^a,b   Hao, Sheng Po ^a   Liu, Chun Ting ^a   Cheng, Ming Huei ^a   Chang, Yu Liang ^a   Lee, Yun Shien ^a,c   Wang, Tzu Hao ^a   Tsai, Chi Neu ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c MING CHUAN UNIVERSITY   (Taiwan)

Author keywords

DNA methyltransferase 3B (DNMT3B); Head and neck; Single nucleotide polymorphism (SNP); Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNMT3B GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK; TAIWAN;

EID: 33947202667     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.04.006     Document Type: Article

References (27)

1. Vokes E.E., Weichselbaum R.R., Lippman S.M., and Hong W.K. Head and neck cancer. New Engl J Med 328 (1993) 184-194
2. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
3. Boring C.C., Squires T.S., Tong T., and Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 44 (1994) 7-26
4. Silverman Jr. S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 (2001) 7S-11S
5. Momparler R.L., and Bovenzi V. DNA methylation and cancer. J Cell Physiol 183 (2000) 145-154
6. Bestor T.H. The DNA methyltransferases of mammals. Hum Mol Genet 9 (2000) 2395-2402
7. Hermann A., Gowher H., and Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61 (2004) 2571-2587
8. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33 (2003) 61-65
9. Szyf M. The role of DNA methyltransferase 1 in growth control. Front Biosci 6 (2001) 599-609
10. Hsieh C.L. Dynamics of DNA methylation pattern. Curr Opin Genet Dev 10 (2000) 224-228
11. Robertson K.D., Keyomarsi K., Gonzales F.A., Velicescu M., and Jones P.A. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res 28 (2000) 2108-2113
12. Nagai M., Nakamura A., Makino R., and Mitamura K. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res 26 (2003) 186-191
13. Yakushiji T., Uzawa K., Shibahara T., Noma H., and Tanzawa H. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 22 (2003) 1201-1207
14. Shen H., Wang L., Spitz M.R., Hong W.K., Mao L., and Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 62 (2002) 4992-4995
15. Singal R., Das P.M., Manoharan M., Reis I.M., and Schlesselman J.J. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Oncol Rep 14 (2005) 569-573
16. Li Y., Dai Y., Wu S.L., Pei P., Cao X.H., and Pu D.F. The C46359T polymorphism of DNMT3B promoter gene and pathogenesis of acute leukemia. Zhonghua Nei Ke Za Zhi 44 (2005) 588-591
17. Lee S.J., Jeon H.S., Jang J.S., Park S.H., Lee G.Y., Lee B.H., et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26 (2005) 403-409
18. Sun X., Ding H., Hung K., and Guo B. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res 28 (2000) E68
19. Liao H.K., Su Y.N., Kao H.Y., Hung C.C., Wang H.T., and Chen Y.J. Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for beta-thalassemia mutations. J Hum Genet 50 (2005) 139-150
20. Stanssens P., Zabeau M., Meersseman G., Remes G., Gansemans Y., Storm N., et al. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 14 (2004) 126-133
21. Lin F., Dowdy S.C., Xiong Y., Eberhardt N.L., Podratz K.C., and Jiang S.W. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol 96 (2005) 531-538
22. Montgomery K.G., Liu M.C., Eccles D.M., and Campbell I.G. The DNMT3B C → T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 6 (2004) 390-394
23. Aung P.P., Matsumura S., Kuraoka K., Kunimitsu K., Yoshida K., Matsusaki K., et al. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 14 (2005) 1151-1154
24. Wang Y.M., Wang R., Wen D.G., Li Y., Guo W., Wang N., et al. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. World J Gastroenterol 11 (2005) 3623-3627
25. Wang L., Rodriguez M., Kim E.S., Xu Y., Bekele N., El-Naggar A.K., et al. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int J Oncol 25 (2004) 993-999
26. Jinawath A., Miyake S., Yanagisawa Y., Akiyama Y., and Yuasa Y. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385 (2005) 557-564
27. Yanagisawa Y., Ito E., Yuasa Y., and Maruyama K. The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim Biophys Acta 1577 (2002) 457-565